Chemomab Therapeutics Ltd.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2018 | $-14.2M | $-14.4M | $213.0K | $1.9M |
| FY2019 | $-16.5M | $-16.6M | $95.0K | $1.2M |
| FY2020 | $-5.2M | $-5.3M | $38.0K | $130.0K |
| FY2021 | $-12.4M | $-12.6M | $239.0K | $2.0M |
| FY2022 | $-20.4M | $-20.4M | $68.0K | $3.2M |